Volume 1, Issue 3
Editorialp. 359
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Author(s): Tadeusz Robak, Piotr Smolewski2
Editorialp. 363
New therapeutics for pulmonary arterial hypertension: do gene therapies have translational values?
Author(s): Roxane Paulin, Marjorie Barrier, Sebastien Bonnet
News and Viewsp. 371–374
Phase III study shows promising results for personalized medicine in advanced melanoma
Review Articlep. 375-380
Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net)
Author(s): Jose Cunha-Vaz,Ceclia Martinho
Review Articlep. 381
Parkinsons disease: will therapy move beyond dopaminergic medication?
Author(s): Livia Dezsi,L Vecsei
Review Articlep. 399
Use of pharmacogenomics in psoriasis
Author(s): Caitriona Ryan, Anne Bowcock, Alan Menter
Review Articlep. 413
New advances in the treatment of endometrial cancer
Author(s): Dario R Roque, Don S Dizon
Review Articlep. 423–428
Design, findings and implications of the RECORD study program
Author(s): Lars Carl Borris
Review Articlep. 429–437
Role of ticagrelor in the treatment of coronary artery disease
Author(s): Udaya S Tantry, Dean J Kereiakes, Paul A Gurbel
Review Articlep. 439–445
Update on recent trials in the treatment of hereditary angioedema
Author(s): Neelu Kalra,Timothy Craig
Review Articlep. 447–457
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Author(s): Jutta Auberger, Cornelia Lass-Flori
Review Articlep. 459–465
Certolizumab pegol in the treatment of Crohns disease: evidence from the PRECiSE clinical trial program
Author(s): Ian C Lawrance
Review Articlep. 467
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Author(s): Kristina Gemzell-Danielsson,Sharon T Cameron
Acknowledgementsp. 603
